DekaBank Deutsche Girozentrale
PTGX icon

DekaBank Deutsche Girozentrale’s Protagonist Therapeutics PTGX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,800
Closed -$489K – 1299
2025
Q4 		$489K Hold
15,800
– – ﹤0.01% 1004
2025
Q3 		$1.03M Hold
15,800
– – ﹤0.01% 867
2025
Q2 		$879K Hold
15,800
– – ﹤0.01% 889
2025
Q1 		$771K Hold
15,800
– – ﹤0.01% 889
2024
Q4 		$610K Hold
15,800
– – ﹤0.01% 962
2024
Q3 		$709K Hold
15,800
– – ﹤0.01% 944
2024
Q2 		$555K Hold
15,800
– – ﹤0.01% 987
2024
Q1 		$461K Hold
15,800
– – ﹤0.01% 1015
2023
Q4 		$326K Hold
15,800
– – ﹤0.01% 1115
2023
Q3 		$271K Hold
15,800
– – ﹤0.01% 1144
2023
Q2 		$438K Hold
15,800
– – ﹤0.01% 1046
2023
Q1 		$357K Hold
15,800
– – ﹤0.01% 1086
2022
Q4 		$154K Hold
15,800
– – ﹤0.01% 1260
2022
Q3 		$131K Hold
15,800
– – ﹤0.01% 1281
2022
Q2 		$140K Hold
15,800
– – ﹤0.01% 1245
2022
Q1 		$378K Buy
15,800
+1,400
+10% +$39.4K ﹤0.01% 1109
2021
Q4 		$439K Buy
14,400
+400
+3% +$12.6K ﹤0.01% 1129
2021
Q3 		$246K Hold
14,000
– – ﹤0.01% 1168
2021
Q2 		$616K Hold
14,000
– – ﹤0.01% 1026
2021
Q1 		$354K Hold
14,000
– – ﹤0.01% 1081
2020
Q4 		$300K Buy
+14,000
New +$301K ﹤0.01% 1122

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PTGX Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Protagonist Therapeutics (PTGX) in Q1 2026, closing a stake of 15,800 shares — an estimated $489K sold.

DekaBank Deutsche Girozentrale first reported a position in PTGX in Q4 2020 and held it in 21 quarters. The position peaked at $1.03M in Q3 2025. 319 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • DekaBank Deutsche Girozentrale reported no remaining Protagonist Therapeutics position as of Q1 2026 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 15,800 Protagonist Therapeutics shares in Q1 2026, an estimated $489K.
  • DekaBank Deutsche Girozentrale first reported a position in Protagonist Therapeutics in Q4 2020 and held it in 21 quarters.
  • DekaBank Deutsche Girozentrale's Protagonist Therapeutics position peaked at $1.03M in Q3 2025.
  • 319 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.